Asia-Pacific Blood Screening Market to 2032

Overview

The Asia-Pacific Blood Screening Market is expected to reach a 935.61 USD Million by 2032 and is projected to grow at a CAGR of 13.89% from 2025 to 2032.

Revenue, 2024 (USD Million)

417.82

Forecast, 2032 (USD Million)

935.61

CAGR, 2024 - 2032

13.89%

Report Coverage

Asia-Pacific

Asia-Pacific Blood Screening Market 2018-2032 USD Million

Asia-Pacific Blood Screening Market, Key Findings (2025-2032)

Market Growth and Projections:

Market Size (2024): 417.82 USD Million
Projected Market Size (2032): 935.61 USD Million
CAGR (2025-2032): 13.89%

Key Findings of Asia-Pacific Blood Screening Market

The Asia-Pacific Blood Screening Market was valued at 417.82 USD Million in 2024.
The Asia-Pacific Blood Screening Market is likely to grow at a CAGR of 13.89% during the forecast period of 2024 to 2032.
In 2024, the Largest segment Reagents & Kits in Products & Services Segment accounted for the largest share of the market with a revenue of 207.53 USD Million
The fastest growing segment Next-Generation Sequencing (NGS) in Technology Segment grew Fastest with a CAGR of 14.82% during the forecast period from 2024 to 2032.

Asia-Pacific Blood Screening Market Scope

Asia-Pacific Blood Screening Market Segmentation & Scope

Technology

Others
Western Blot Assay
Nucleic Acid Test
Next-Generation Sequencing (NGS)
Rapid Tests
Enzyme-Linked Immunosorbent Assay (ELISA)

Disease Type

Others
HIV/AIDS
Respiratory Diseases
Infectious Diseases
Cholesterol
Cold & Flu
Diabetes Mellitus
Oncology

Products & Services

Software & Services
Instruments
Reagents & Kits

End User

Ambulatory Surgical Centers
Clinics
Hospitals
Blood Bank
Diagnostic Centers

Asia-Pacific Blood Screening Market Data Coverage Insights

Study Period	2024-2032
Base Year	2022
Unit	Revenue in USD Million
Market Value in 2024	417.82 USD Million
Market Value in 2032	935.61 USD Million
CAGR (2025-2032)	13.89%
Historic Data	2016-2023
Market Segments Covered	Technology,Disease Type,Products & Services,End User

Regional Insights:

Leading Market (2024-2032): Asia-Pacific, leading in terms of revenue 417.82 USD Million in 2024
- Key Country: China, leading in terms of revenue with value of 111.00 USD Million in 2024.

Segments and Scope

Asia-Pacific Blood Screening Market to 2032, By Technology
- Enzyme-Linked Immunosorbent Assay (ELISA) is the largest segment in Asia-Pacific Blood Screening Market to 2032 with a revenue of 133.18 USD Million in the year 2024.
- Next-Generation Sequencing (NGS) is the Fastest growing segment in Asia-Pacific Blood Screening Market to 2032 with a Growth rate of 13.97 % in forecast period 2025-2032.
Asia-Pacific Blood Screening Market to 2032, By Disease Type
- Oncology is the largest segment in Asia-Pacific Blood Screening Market to 2032 with a revenue of 120.32 USD Million in the year 2024.
- Oncology is the Fastest growing segment in Asia-Pacific Blood Screening Market to 2032 with a Growth rate of 14.67 % in forecast period 2025-2032.
Asia-Pacific Blood Screening Market to 2032, By Products & Services
- Reagents & Kits is the largest segment in Asia-Pacific Blood Screening Market to 2032 with a revenue of 207.53 USD Million in the year 2024.
- Instruments is the Fastest growing segment in Asia-Pacific Blood Screening Market to 2032 with a Growth rate of 13.65 % in forecast period 2025-2032.
Asia-Pacific Blood Screening Market to 2032, By End User
- Diagnostic Centers is the largest segment in Asia-Pacific Blood Screening Market to 2032 with a revenue of 132.15 USD Million in the year 2024.
- Diagnostic Centers is the Fastest growing segment in Asia-Pacific Blood Screening Market to 2032 with a Growth rate of 14.74 % in forecast period 2025-2032.

Asia-Pacific Blood Screening Market Company Share Analysis

Company Name
INNOVUS PHARMACEUTICALS, INC.
Pfizer Inc.
Bayer AG
Cipla Inc.
GSK plc.

Asia-Pacific Blood Screening Market Geographical Sales Distribution, 2018-2032 USD Million

Asia-Pacific Blood Screening Market Company Profiling

Industry Related Reports

South America Cell And Gene Therapy Thawing Equipment Market

Middle East & Africa Cell And Gene Therapy Thawing Equipment Market

North America Cell And Gene Therapy Thawing Equipment Market

Europe Cell And Gene Therapy Thawing Equipment Market

Asia-Pacific Cell And Gene Therapy Thawing Equipment Market

Argentina Cell And Gene Therapy Thawing Equipment Market

Australia Cell And Gene Therapy Thawing Equipment Market

Belgium Cell And Gene Therapy Thawing Equipment Market

Brazil Cell And Gene Therapy Thawing Equipment Market

Canada Cell And Gene Therapy Thawing Equipment Market

Frequently Asked Questions

What are the primary segments covered in the Asia-Pacific Blood Screening Market?

The Asia-Pacific Blood Screening Market is segmented based on Segmentation Technology,Disease Type,Products & Services,End User.

What is the current market size of the Asia-Pacific Blood Screening Market?

Asia-Pacific Blood Screening Market was valued at USD 417.82(Revenue in USD Million) in 2022.

What is the expected growth rate of the Asia-Pacific Blood Screening Market?

Asia-Pacific Blood Screening Market is projected to grow at a CAGR of 13.89% during the forecast period of 2024 to 2032.

Which is the dominating segment in the Asia-Pacific Blood Screening Market?

The Reagents & Kits segment is expected to dominate the Asia-Pacific Blood Screening Market, holding a largest market share of 207.53 USD Million in 2024